Screening revision! By Ilona Blee. What are some UK Screening programmes?  Antenatal & newborn screening  Newborn Blood Spot  Newborn Hearing Screening.

Slides:



Advertisements
Similar presentations
Screening and Prevention
Advertisements

Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
Screening programmes Practice nurse forum 13 th January 2009.
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
GerstmanChapter 41 Epidemiology Kept Simple Chapter 4 Screening for Disease.
Diagnosis, screening and prevention. Puzzle Virus present randomly in 1 in 1000 population Test for virus 99% reliable –i.e. misses 1% of infected individuals.
1 Comunicación y Gerencia 18/4/2011Dr Salwa Tayel (Screening) بسم الله الرحمن الرحيم.
Screening. Screening refers to the application of a test to people who are as yet asymptomatic for the purpose of classifying them with respect to their.
Statistics for Health Care
Prof. Wasantha Gunathunga.  Primary  Secondary  Tertiary.
Wilson and Jungner Criteria for Screening 1968
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
Screening PHIL THIRKELL. What is screening?  A process of identifying apparently healthy people who may be at risk of a disease or condition  Identify.
© Open University Press, 2004 Overview Prevention and screening Psychological predictors of screening The ethics and usefulness of screening? Psychological.
Cervical screening Tim Wright Sept 07. Introduction What who when What who when Benefits (evidence) Benefits (evidence) Cost Cost Does it fit wilson’s.
Ethical issues and cancer screening. Efficacy The extent to which a specific intervention, procedure, regimen, or service produces a beneficial result.
Thomas B. Newman, MD, MPH Andi Marmor, MD, MSEd October 21, 2010.
Screening Dr Gerry Bryant. What is screening? Systematic application of a test or enquiry, to identify individuals at sufficient risk of a specific disorder.
Screening Introduction to Primary Care:
Basic statistics 11/09/13.
Interpreting numbers – more tricky bits ScotPHO training course March 2011 Dr Gerry McCartney Head of Public Health Observatory Division NHS Health Scotland.
Principles and Predictive Value of Screening. Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity.
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Sensitivity & Specificity Sam Thomson 8/12/10. Sensitivity Proportion of people with the condition who have a positive test result Proportion of people.
1 Epidemiological Measures I Screening for Disease.
Ann Jolly1 Screening “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...” “...sort.
Chapter 10 Screening for Disease
 Volunteer bias  Lead time bias  Length bias  Stage migration bias  Pseudodisease.
Screening Puja Myles
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Principles of Screening
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Women’s Health Evening Portishead Medical Group Monday 12 th October pm.
Predictive values prevalence CK and acute myocardial infarction –sensitivity 70% –specificity 80% –prevalence - 40% –prevalence - 20% –PPV and NPV.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
[State] Newborn Screening Public Policy [Members Names]
12/12/2009Dr. Salwa Tayel1 Comunicación y Gerencia.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
TUTORIAL: SCREENING. PERFORMANCE OBJECTIVES Compute and interpret Sensitivity Specificity Predictive value positive Predictive value negative False positive.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Clinical Epidemiology
Insert name of presentation on Master Slide
Insert name of presentation on Master Slide
Principles of Epidemiology E
Class session 7 Screening, validity, reliability
Interpreting numbers – more tricky bits
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
Comunicación y Gerencia
How do we delay disease progress once it has started?
Public Health Phase 3A Abigail Aitken
Newborn screening and the future – Where do we go from here?
Screening, Sensitivity, Specificity, and ROC curves
Dr. Hannah Jordan Lecturer in Public Health ScHARR
No matter what the type of genetic screening, certain core principles should be followed before a program is introduced. Principles of Screening • The.
Screening and Prevention
Presentation transcript:

Screening revision! By Ilona Blee

What are some UK Screening programmes?  Antenatal & newborn screening  Newborn Blood Spot  Newborn Hearing Screening  Chlamydia screening  Screening for bowel cancer – fecal occult blood  Abdominal aortic aneurysm  Breast cancer   Have an idea of what these conditions are screening for!

What are pregnant women screened for?  High blood pressure  Diabetes mellitus  Pre-eclampsia  Infectious diseases like hepatitis B, HIV, syphilis & rubella

What conditions does the newborn blood spot screen for?  Sickle cell disease  Cystic fibrosis  Congenital hypothyroidism  Inherited metabolic diseases  maple syrup urine disease or phenylketonuria 

What is the name of the criteria for a screening programme?  Wilson & Jugner criteria  What is the purpose of the Wilson & Jugner criteria?  To assess the effectiveness and appropriateness of screening programmes  What are the Wilson & Jugner criteria?

WILSON & JUGNER CRITERIA 1. Condition should be an important health problem 2. Condition should have an existing treatment for it 3. Condition should have a latent stage 4. The natural history of the condition should be known and understood 5. A test for the condition/disease should exist 6. The test available should be accepted by the population 7. Test should be cost effective/financially viable 8. Facilities for diagnosis & treatment should be available 9. Case-finding should be a continuous process, not just a one-off 10. Agreed upon policy on whom to treat

Classifying Test Results

What is sensitivity?  The proportion of people who have the disease (true positive) that the test correctly detects  Mathematically = true positive / (true positive + false negative)  So if you have the disease, sensitivity tells you the probability of the test picking up the disease

What is specificity?  The proportion of people who do not have the disease (true negatives) that the test correctly identifies as not having the disease  Mathematically = true negatives / (true negatives + false positives)  Sensitivity & specificity measure test performance

Positive predictive value  The probability that a person has the disease (true positive) given that that have had a positive test result (all the positives)  Mathematically = true positives / (true positives + false positives)  With lower disease prevalence, there will be a lower positive predictive value  Define prevalence  The number of people in a defined population with a disease at a given time  What are TWO types of prevalence? 1. Point 2. Period

Negative predictive value  The probability that a person does not have the disease (true negative) given that they have a negative test result (all the negatives)  Mathematically = true negatives / (true negatives + false negatives)  Positive & negative predictive value tell us about disease prevalence and test performance

Disease Positive Diseased Negative Test positive True PositiveFalse Positive Positive Predictive Value TP / (TP + FP) Test negative False NegativeTrue Negative Negative Predictive Value TN / (TN + FN) Sensitivity TP / (TP + FN) Specificity TN / (TN + FP)

List the FOUR types of screening bias 1. Healthy screenee 2. Length time effect 3. Lead time effect 4. Overdiagnosis

The healthy screenee – what does this mean?  Patients who are active about looking after themselves and their health; these people are more likely to attend screening programmes and are less likely to have a positive result.  People who don’t attend are more likely to smoke, drink and have low income  Patients like this could be described to have an “internal locus of control”  What THREE things do people with an internal locus of control believe? 1. That they are responsible for their own health 2. Illness can be avoided by good health behaviours 3. Ill health is due to poor health behaviour

Length time effect – what is this?  Screening is better at detecting disease that develops more slowly and so the prognosis is better for these conditions.  Therefore, because the slower conditions have a “better” prognosis, it looks like screening helps with their outcome  In reality, screening just isn’t catching the fast forming conditions that have a poor prognosis and result in death

Lead time effect – what is this?  Screening is able to detect a disease earlier and can make it look like, as a result of the screening the survival time has been increased ie. The prognosis looks like it is longer but it actually doesn’t have an impact on the outcome  For example we have two people with cancer. The first one is screened and given a 10 year prognosis.  The second isn’t screened, goes 5 years with no symptoms, and is then given a prognosis time of 5 years. The person who was screened looks like they have a better prognosis. SCREENING SYMPTOMS Lead Time

Overdiagnosis – what does this mean?  Patients are diagnosed with a condition that isn’t going to cause symptoms in the patients lifetime.  E.g. prostate cancer. Become more diagnosed following prostate specific antigen (PSA) screening  Ended up just making patients anxious and shouldn’t be done in patients with a limited life expectancy

Thank-you!  Any questions?  Good luck with your revision